Trials / Terminated
TerminatedNCT01609036
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Follicular Lymphoma
An Observational Phase IV Non Interventional Study in Patients With Advanced Follicular Lymphoma (III-IV) Evaluating the Safety of Maintenance Therapy With Rituximab After 8 Cycles of Rituximab in Combination With Chemotherapy as Induction Therapy in Previously Untreated Patients in Greece.
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 3 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This observational study will evaluate the safety and efficacy of MabThera/Rituxan (rituximab) in previously untreated patients with follicular lymphoma. Data will be collected for 3 years
Conditions
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2012-11-01
- Completion
- 2012-11-01
- First posted
- 2012-05-31
- Last updated
- 2016-11-02
Locations
4 sites across 1 country: Greece
Source: ClinicalTrials.gov record NCT01609036. Inclusion in this directory is not an endorsement.